Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study

被引:67
作者
Chaiworapongsa, Tinnakorn [1 ,2 ]
Romero, Roberto [1 ]
Korzeniewski, Steven J. [1 ,2 ]
Cortez, Josef M. [3 ]
Pappas, Athina [3 ]
Tarca, Adi L. [1 ,4 ]
Chaemsaithong, Piya [1 ,2 ]
Dong, Zhong [1 ]
Yeo, Lami [1 ,2 ]
Hassan, Sonia S. [1 ,2 ]
机构
[1] NICHD, Perinatol Res Branch, NIH, DHHS, Detroit, MI USA
[2] Wayne State Univ, Dept Obstet Gynecol, Detroit, MI 48201 USA
[3] Wayne State Univ, Dept Pediat, Detroit, MI 48201 USA
[4] Wayne State Univ, Dept Comp Sci, Detroit, MI 48201 USA
基金
美国国家卫生研究院;
关键词
Maternal outcome; neonatal outcome; placental growth factor; pregnancy; soluble endoglin; soluble vascular endothelial growth factor receptor-1; ELEVATED LIVER-ENZYMES; GROWTH-FACTOR RECEPTOR-1; LOW PLATELET COUNT; SERUM URIC-ACID; GESTATIONAL HYPERTENSION; SOLUBLE ENDOGLIN; MATERNAL COMPLICATIONS; EARLY-ONSET; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; INTRAVASCULAR COAGULATION;
D O I
10.3109/14767058.2013.806905
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To prospectively determine the prognostic value of maternal plasma concentrations of placental growth factor (PlGF), soluble endoglin (sEng) and soluble vascular endothelial growth factor receptors-1 and -2 (sVEGFR-1 and -2) in identifying patients with suspected preeclampsia (PE), who require preterm delivery (PTD) or develop adverse outcomes. Study design: This prospective cohort study included 85 consecutive patients who presented to the obstetrical triage area at 20-36 weeks with a diagnosis of "rule out PE." Patients were classified as: 1) those who remained stable until term (n = 37); and 2) those who developed severe PE and required PTD (n = 48). Plasma concentrations of PlGF, sEng and sVEGFR-1 and -2 were determined by ELISA. Results: Patients with PlGF/sVEGFR-1 <= 0.05 multiples of the median (MoM) or PlGF/sEng <= 0.07 MoM were more likely to deliver preterm due to PE [adjusted odd ratio (aOR) 7.4 and 8.8], and to develop maternal (aOR 3.7 and 2.4) or neonatal complications (aOR 10.0 and 10.1). Among patients who presented <34 weeks of gestation, PlGF/sVEGFR-1 <= 0.035 MoM or PlGF/sEng <= 0.05 MoM had a sensitivity of 89% (16/18), specificity of 96% (24/25) and likelihood ratio for a positive test of 22 to identify patients who delivered within 2 weeks. The addition of the PlGF/sVEGFR-1 ratio to standard clinical tests improved the sensitivity at a fixed false-positive rate of 3% (p = 0.004) for the identification of patients who were delivered due to PE within 2 weeks. Among patients who had a plasma concentration of PlGF/sVEGFR-1 ratio <= 0.035 MoM, 0.036-0.34 MoM and >= 0.35 MoM, the rates of PTD <34 weeks were 94%, 27% and 7%, respectively. Conclusions: The determination of angiogenic/anti-angiogenic factors has prognostic value in patients presenting to the obstetrical triage area with suspected PE for the identification of those requiring preterm delivery and at risk for adverse maternal/neonatal outcomes.
引用
收藏
页码:132 / 144
页数:13
相关论文
共 123 条
  • [71] Cytotrophoblasts up-regulate soluble Fms-like tyrosine kinase-1 expression under reduced oxygen: An implication for the placental vascular development and the pathophysiology of preeclampsia
    Nagamatsu, T
    Fujii, T
    Kusumi, M
    Zou, L
    Yamashita, T
    Osuga, Y
    Momoeda, M
    Kozuma, S
    Taketani, Y
    [J]. ENDOCRINOLOGY, 2004, 145 (11) : 4838 - 4845
  • [72] Prediction of maternal and fetal complications in preeclampsia
    Nisell, H
    Palm, K
    Wolff, K
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (01) : 19 - 23
  • [73] ODENDAAL HJ, 1987, S AFR MED J, V71, P555
  • [74] Cerebral hemodynamics and autoregulation in reversible posterior leukoencephalopathy syndrome caused by pre-/eclampsia
    Oehm, Eckard
    Hetzel, Andreas
    Els, Thomas
    Berlis, Ansgar
    Keck, Christoph
    Will, Hans-Gerd
    Reinhard, Matthias
    [J]. CEREBROVASCULAR DISEASES, 2006, 22 (2-3) : 204 - 208
  • [75] Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]
  • [76] Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia
    Ohkuchi, Akihide
    Hirashima, Chikako
    Suzuki, Hirotada
    Takahashi, Kayo
    Yoshida, Mika
    Matsubara, Shigeki
    Suzuki, Mitsuaki
    [J]. HYPERTENSION RESEARCH, 2010, 33 (05) : 422 - 427
  • [77] Serum sFlt1:PlGF Ratio, PlGF, and Soluble Endoglin Levels in Gestational Proteinuria
    Ohkuchi, Akihide
    Hirashima, Chikako
    Matsubara, Shigeki
    Suzuki, Hirotada
    Takahashi, Kayo
    Usui, Rie
    Suzuki, Mitsuaki
    [J]. HYPERTENSION IN PREGNANCY, 2009, 28 (01) : 95 - 108
  • [78] ONEY T, 1990, J HYPERTENS, V8, pS77
  • [79] INCIDENCE AND EVOLUTION OF SUBEPENDYMAL AND INTRA-VENTRICULAR HEMORRHAGE - STUDY OF INFANTS WITH BIRTH WEIGHTS LESS THAN 1,500 GM
    PAPILE, LA
    BURSTEIN, J
    BURSTEIN, R
    KOFFLER, H
    [J]. JOURNAL OF PEDIATRICS, 1978, 92 (04) : 529 - 534
  • [80] Impedance Cardiography Facilitates Differentiation of Severe and Superimposed Preeclampsia from Other Hypertensive Disorders
    Parrish, Marc R.
    Laye, M. Ryan
    Wood, Tommy
    Keiser, Sharon D.
    Owens, Michelle Y.
    May, Warren L.
    Martin, James N., Jr.
    [J]. HYPERTENSION IN PREGNANCY, 2012, 31 (03) : 327 - 340